SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Argentina · Delayed Price · Currency is USD
0.33-0.01 (-1.54%)
 
Market Cap20.82M-74.2%
Revenue (ttm)246.31M-24.3%
Net Income-230.17M-315.3%
EPS-3.58-343.9%
Shares Out63.23M
PE Ration/a
Forward PE0.59
Dividendn/a
Ex-Dividend Daten/a
Volume16,996
Open0.32
Previous Close0.33
Day's Range0.32 - 0.34
52-Week Range0.30 - 2.19
Beta0.47
AnalystsBuy
Price Target8.00(+2329.03%)
Earnings DateNov 12, 2026
-1.35% (1D)
No price history available.
Insider Score
––Not scored
BIOX Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

About BIOX

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Address
Ocampo 210 bis, Rosario, 2000, Argentina
Market Cap
21 million
Employees
—
Industrial Classification
Agricultural Inputs
1 Day
-1.47%
5 Days
-3.74%
1 Month
-20.62%
6 Months
-42.24%
1 Year
-74.23%

$BIOX stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BIOX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BIOX's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BIOX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BIOX Revenue by Segment or Geography

BIOX's latest filing doesn't break out revenue by segment.

Source: SEC EDGAR (10-Q/10-K)

U.S. Patents

New BIOX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BIOX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in BIOX

ETFEst. Holding Size
ARGTGlobal X - MSCI Argentina ETF$390.50K

Estimated from each fund’s disclosed top holdings × AUM

BIOX Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for BIOX yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from BIOX’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.